4th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference

16th - 17th June 2022 | Double Tree by Hilton San Diego- Mission Valley
CONFERENCE SPEAKERS
Advisors
 Julius Goepp
Julius Goepp
Founder, CEO,
Scaled Microbiomics


Julius Goepp is the founder and CEO of Scaled Microbiomics, LLC, a pre-clinical stage biotech company focused on passive immunotherapy in the microbiome. Dr. Goepp trained in Pediatrics and Emergency Medicine at Children’s Hospital, Boston, and in Pediatric Infectious Disease at Johns Hopkins, where he was active in the promotion of Oral Rehydration Therapy for childhood diarrheal disease. In 2017, he founded Scaled Microbiomics after recognizing the potential for microbiome modulation through the use of little-known avian antibodies, or IgY. Since that time, his energies have been devoted to exploring the characteristics of those antibodies and developing a drug discovery platform based on their use as selective immunomodulators of complex microbiome signaling pathways and event cascades. In addition to his work, Goepp is passionate about cooking, flying, and exploring the outdoors.


 Emily Stein
Emily Stein
CEO,
Primal Health Inc.


Ph.D. founded Primal Health, LLC in 2017 to focus on improving the dental health of both humans and animals by producing oral microbiome modulation products. She has spent 12 years developing SMMRT technology at Primal Therapies, Inc., which is focused on using metabolic influencers to re-engineer disease-causing bacterial biofilms into those that are health-promoting, to decrease inflammation and to improve outcomes. Prior to that, she spent 7 years as a research fellow at Stanford University in Rheumatology and Immunology focused on the neuro-endocrine-immune axis in autoimmune and chronic inflammatory diseases. She holds a Ph.D. in Microbiology from the University of California at Berkeley where she studied inter- and intra-cellular signaling pathways involved in stress response and community development in bacteria and received her B.S. in Microbiology and Immunology at the University of Iowa where she studied the interaction between M. tuberculosis and innate immune cells.


Yug Varma
Yug Varma
CEO,
Phi Therapeutics


Yug Varma, PhD, is the cofounder and CEO of Phi Therapeutics, a venture-backed microbiome company focused on skin disorders based in San Francisco. He has an extensive background in bio-organic chemistry, microbiology, synthetic biology, and microbiome research. Yug received

his scientific training at several distinguished academic institutions, including Johns Hopkins University (PhD) and University of California, San Francisco


 Nicole M. Scott
Nicole M. Scott
CEO and Founder,
Cybele Microbiome


Nicole is a domain expert in the microbiome and data science who has spent the last 6 years in startups doing everything from marketing, business strategy, IP, data analysis, and fundraising. She studied at the University of Michigan and University of Chicago with Dr. Jack Gilbert, and was the first employee at Dr. Rob Knight’s microbiome startup Biota. She is cited more than 2000 times, published in prestigious journals such as Science and Nature, and is the author of several book chapters and patents. She also serves as an advisor to several other life science and biotech startups.


Speakers
 Julius Goepp
Julius Goepp
Founder, CEO,
Scaled Microbiomics


Julius Goepp is the founder and CEO of Scaled Microbiomics, LLC, a pre-clinical stage biotech company focused on passive immunotherapy in the microbiome. Dr. Goepp trained in Pediatrics and Emergency Medicine at Children’s Hospital, Boston, and in Pediatric Infectious Disease at Johns Hopkins, where he was active in the promotion of Oral Rehydration Therapy for childhood diarrheal disease. In 2017, he founded Scaled Microbiomics after recognizing the potential for microbiome modulation through the use of little-known avian antibodies, or IgY. Since that time, his energies have been devoted to exploring the characteristics of those antibodies and developing a drug discovery platform based on their use as selective immunomodulators of complex microbiome signaling pathways and event cascades. In addition to his work, Goepp is passionate about cooking, flying, and exploring the outdoors.


 Emily Stein
Emily Stein
CEO,
Primal Health Inc.


Ph.D. founded Primal Health, LLC in 2017 to focus on improving the dental health of both humans and animals by producing oral microbiome modulation products. She has spent 12 years developing SMMRT technology at Primal Therapies, Inc., which is focused on using metabolic influencers to re-engineer disease-causing bacterial biofilms into those that are health-promoting, to decrease inflammation and to improve outcomes. Prior to that, she spent 7 years as a research fellow at Stanford University in Rheumatology and Immunology focused on the neuro-endocrine-immune axis in autoimmune and chronic inflammatory diseases. She holds a Ph.D. in Microbiology from the University of California at Berkeley where she studied inter- and intra-cellular signaling pathways involved in stress response and community development in bacteria and received her B.S. in Microbiology and Immunology at the University of Iowa where she studied the interaction between M. tuberculosis and innate immune cells.


Yug Varma
Yug Varma
CEO,
Phi Therapeutics


Yug Varma, PhD, is the cofounder and CEO of Phi Therapeutics, a venture-backed microbiome company focused on skin disorders based in San Francisco. He has an extensive background in bio-organic chemistry, microbiology, synthetic biology, and microbiome research. Yug received

his scientific training at several distinguished academic institutions, including Johns Hopkins University (PhD) and University of California, San Francisco


 Nicole M. Scott
Nicole M. Scott
CEO and Founder,
Cybele Microbiome


Nicole is a domain expert in the microbiome and data science who has spent the last 6 years in startups doing everything from marketing, business strategy, IP, data analysis, and fundraising. She studied at the University of Michigan and University of Chicago with Dr. Jack Gilbert, and was the first employee at Dr. Rob Knight’s microbiome startup Biota. She is cited more than 2000 times, published in prestigious journals such as Science and Nature, and is the author of several book chapters and patents. She also serves as an advisor to several other life science and biotech startups.


Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer,
Dakota Biotech


Maya Ivanjesku M.S. is a creative visionary, CSO and a formulation scientist at Dakota Biotech -The Live Probiotic Skincare company. With over 25 years of experience in developing products for the beauty industry, Maya is a formulation expert. Her career path started at Estee Lauder Companies where she was formulating products for Estee Lauder, Clinique, Origins, Bobby Brown, Aveda, LaMer etc. With her passion for science and nature, Maya also ventured into Biotech, OTC and topical Rx and Medical Device formulation and developed topical prescription formulas for numerous pharmaceutical companies. The diversity of her career path in formulating products, overseeing manufacturing, R&D and holding executive positions in numerous industries from cosmetic to pharmaceutical and biotech product launches, has lead Maya into an entrepreneurial opportunity at Dakota Biotech where LaFloreÒ Probiotic Skincare product line was born. Maya’s passion for wellness, education and helping people heal – naturally, is the main driver in developing performance focused products.


Arun Bhunia
Arun Bhunia
Professor of Food Microbiology,
Purdue University


Prof. Arun K. Bhunia received his Bachelor of Veterinary Science (BVSc) degree from India, PhD from the University of Wyoming (USA), and postdoctoral training from the University of Arkansas (USA). He is a professor of food microbiology in the Department of Food Science and is also affiliated with the Department of Comparative Pathobiology, Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D), and Purdue University Life Science program (PULSe). He is chair of the Interdepartmental Food Science Graduate Program. His expertise is in the area of microbial pathogenesis (host-pathogen interaction), probiotic bioengineering and foodborne pathogen detection. To date, he has co-authored more than 188 research publications, 2 textbooks (Fundamental Food Microbiology; Foodborne Microbial Pathogens–Mechanisms and Pathogenesis), edited 4 books, and delivered over 140 talks. He served in the USDA National Advisory Committee on Microbiological Criteria for Foods (NACMCF; 2013-2017) and has received Purdue Agriculture Research Award (2003), Purdue Faculty Scholar (2005), Purdue Team Award (2006), IFT R&D Award (2009), Outstanding Graduate Educator Award at Purdue (2013), Fulbright Specialist (2016-2021), and Maurice Weber Laboratorian Award from IAFP (2017).


Ryan Toma
Ryan Toma
Research Scientist,
Viome


Ryan Toma is a research scientist at Viome, a data-driven precision nutrition company with the aim of revolutionizing healthcare from symptoms management to true preventative medicine. Ryan works on the product development and clinical research teams at Viome. He is responsible for the development of technologies that facilitate biomarker discovery as well as the implementation and execution of clinical research programs. Before joining Viome, Ryan worked in the Applied Genomics team at Los Alamos National Laboratory, which developed the core technology used by Viome today


Madeline Lauf
Madeline Lauf
Founder,
Begin Health


Madeline Lauf is the founder and CEO of Begin Health, a toddler and kids’ nutrition health company focused on supporting and nourishing the gut microbiome. Madeline founded Begin Health to empower parents with the knowledge, products and tools to provide the best health beginnings for their kids — starting in the growing, little gut. Madeline is a graduate from the University of Chicago and hopes to help the next generation achieve independent health, through early interventions in gut microbiota composition.


Larry Weiss
Larry Weiss
CEO & Founder,
Symbiome


Larry Weiss is the CEO and Founder of Weiss Bioscience, Inc., a San Franciscobased microbiome research and development company and the manufacturer of Symbiome Skincare products.


Sandrine Miller-Montgomery
Sandrine Miller-Montgomery
Co-Founder, President and CEO,
Micronoma


Sandrine Miller-Montgomery, Pharm.D, Ph.D. is the Co-Founder, President and CEO of Micronoma, the first cancer-detection company using liquid biopsy technology to detect and predict cancer at an early stage of the disease by analyzing the microbial signal with clinical-grade accuracy. Prior to this, she was executive director of UC San Diego’s Center for Microbiome Innovation that she co-led with Dr. Rob Knight. Before her time in academia, she had worked in large biotech and multinational companies as well as start-ups where she excelled at preparing companies for successful exits as shown by her work at Helixis, acquired by Illumina, and MO BIO Labs acquired by QIAGEN.


Dana Buckman
Dana Buckman
CEO/Founder,
BioForm Solutions


Applying over 25 years of flow cytometry experience in cancer and autoimmune research to developing new assays to microbial analysis, leveraging expertise in multicolor flow cytometry and cell sorting for the probiotic industry. Dana worked as a senior scientist for CancerVax, Arena Pharmaceuticals, and Pfizer before forming nanoBioforms in 2014 which became BioForm Solutions in 2016. Dana earned two B.S. degrees, one in BioChemistry and the other in Molecular, Cellular and Developmental Biology at the University of Colorado. Dana is a member of the Southern California Flow Cytometry Association and has served on the program committee for the annual summit since 2016.